Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline
Claus Garbe(University of Tübingen), Alexander M.M. Eggermont(University Medical Center Utrecht), Philippe Saïag(Université de Versailles Saint-Quentin-en-Yvelines), Axel Hauschild(University Hospital Schleswig-Holstein), Josep Malvehy(Universitat de Barcelona), Mark R. Middleton(University of Oxford), Alan Spatz(Jewish General Hospital), Jean‐Jacques Grob(Aix-Marseille Université), Julia Newton‐Bishop(University of Leeds), Ketty Peris(Agostino Gemelli University Polyclinic), Hubert Pehamberger(Medical University of Vienna), Alexander Stratigos(National and Kapodistrian University of Athens)
Cited by 316
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Pembrolizumab versus Ipilimumab in Advanced Melanoma
|New England Journal of Medicine|2015|5.9k
Final Version of 2009 AJCC Melanoma Staging and Classification
|Journal of Clinical Oncology|2009|4.6k
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
|The Lancet|2012|3k
Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
|New England Journal of Medicine|2014|2.7k